Zydus Cadila to provide 1 Cr doses of ZyCoV-D to the center at Rs 265 per dose, Health News, ET HealthWorld
Originally developed by Zydus Cadila, ZyCoV-D is the world’s first known vaccine to use DNA plasmid technology. The vaccine will be delivered via the PharmaJetÂ® needle-free applicator, making it the first needle-free COVID vaccine that can dramatically reduce side effects and help the DNA plasmid reach the desired location for effective immunization.
Speaking on the inclusion of the vaccine in the country’s COVID vaccination campaign, Dr Sharvil Patel, Managing Director, Zydus Cadila, said: âWe are pleased to support the government’s vaccination program with ZyCoV-D. The needleless application of vaccination will hopefully motivate many more to get vaccinated and protect themselves from COVID-19, especially children and young adults 12 to 18 years old. “
ZyCoV-D can be stored at temperatures of around 25 degrees for at least three months without losing its stability. The thermostability of the vaccine provides greater flexibility with the storage and transport of the vaccine compared to others that require freezing temperatures. The company further suggests that DNA plasmid technology offers better protection to deal with any mutations occurring in the virus.